![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 45, 35248-35255, November 10, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, July 10, 2000, and in revised form, August 7, 2000
The nucleosomal ATPase ISWI is the
catalytic subunit of several protein complexes that either organize or
perturb chromatin structure in vitro. This work reports the
cloning and biochemical characterization of a Xenopus ISWI
homolog. Surprisingly, whereas we find four complex forms of ISWI in
egg extracts, we find no functional homolog of NURF. One of these
complexes, xACF, consists of ISWI, Acf1, and a previously
uncharacterized protein of 175 kDa. Like both ACF and CHRAC,
this complex organizes randomly deposited histones into a regularly
spaced array. The remaining three forms include two novel ISWI
complexes distinct from known ISWI complexes plus a
histone-dependent ATPase complex. This comprehensive biochemical characterization of ISWI underscores the evolutionary conservation of the ACF/CHRAC family.
Nuclear DNA in eukaryotic cells is assembled into a nucleoprotein
structure, chromatin, that imposes functional constraints on DNA. The
nuclear processes of transcription (1, 2), replication (3),
recombination (4, 5), and DNA repair (6, 7) are strongly influenced by
chromatin architecture. At least two classes of enzymes remodel
chromatin structure to facilitate DNA function, histone modification
enzymes (2) and energy-dependent motor proteins (8). The
latter category includes both polymerases (9, 10) and SNF2 superfamily
ATPases (11-20). The prototypical member of the SNF2 family, the
SWI2/SNF2 protein, is conserved from yeast to man (12, 15, 20). Both
genetic and biochemical data tie SWI-SNF complex function to
facilitation of transcription within chromatin (11-20). Other
multiprotein complexes containing related SNF2 superfamily members have
been described, including the Mi-2 complex (reviewed in Refs. 11 and
12) as well as several ISWI containing complexes (reviewed in Refs. 12,
19, and 20). The precise in vivo functions of the latter two
categories of enzyme remain largely undefined.
Unlike SWI-SNF complexes that share a common core of subunits (11-20),
ISWI homologs have been described in multiple, distinct complexes (12, 19-20). There are three examples in
Drosophila embryo extracts as follows: NURF (21-22), CHRAC
(23-24), and ACF (25-26). CHRAC and ACF share a common core of
subunits, ISWI and Acf1 (26-28). Human cells contain functional
homologs of CHRAC (27) and ACF (29-30), in addition to the RSF complex
that has no known relatives in other organisms (31). Finally, yeast
contains two forms of ISWI (32), although the relationship of these
complexes to those found in metazoans is currently unknown. All these
complexes, with the notable exception of NURF, share the ability to
organize spaced nucleosomal arrays, suggesting roles for ISWI in
chromatin assembly (21, 24, 25, 27, 29-32). Surprisingly, mutations in
the two ISWI genes in yeast generate no obvious
phenotypes (32), although defects in sporulation have been reported
(33). In contrast, the single ISWI gene in
Drosophila is essential for normal development, and
mutations result in chromosomal defects (34).
In Xenopus laevis, early development proceeds
from fertilization through a series of rapid embryonic cleavages in the
absence of zygotic transcription (35-36). The structural components
and enzymatic machinery for embryonic chromatin assembly are stored in
the egg (37), representing a rich biochemical source. Historically, Xenopus egg (38-40) and oocyte extracts (41) have been
utilized to assemble spaced chromatin in vitro for studies
of transcription (42-43) and DNA repair (44). They contain activities
competent for both spacing of nucleosomal arrays (45) and
mononucleosome disruption (46). We have utilized classical biochemical
techniques for a survey of ISWI from these extracts. This report
outlines the purification of four ISWI complexes. Consistent with the
demands for chromatin assembly during early Xenopus
development, an ACF/CHRAC functional homolog was the most abundant form
identified. In addition, we report the surprising absence of detectable
quantities of NURF.
Isolation of an ISWI
cDNA--
RT-PCR1 was
performed under standard conditions (47) with Xenopus ovary
RNA as template using the following oligonucleotides: sense,
5'CCCAAGCTTCATATGAACTA(T/C)GC(A/T)GTGGATGCCTA(C/T)TT3'; antisense,
5'AAGCTTCTCGAGTTCTTCATATAC(A/G)TT(C/T)TC(C/T)CT(A/G)TCAAA3'. The resulting PCR product was cloned into pGEM-T (Promega) and sequenced. The RT-PCR product was used as a probe for screening an
oocyte cDNA library using standard methods (47). Two overlapping clones were isolated covering the entire ISWI open reading frame. These
clones were sequenced on both strands using an ABI Prism 377 automated
DNA sequencer.
Production of Anti-ISWI Antiserum--
The RT-PCR clone was
excised from pGEM-T with NdeI and XhoI and cloned
into the same sites of pET21a (Novagen). Protein production and
purification under denaturing conditions were performed according to
the manufacturer's instructions (Novagen). Antibodies were produced in
New Zealand White rabbits using a standard immunization protocol
(48).
Purification of ISWI Complexes--
Egg extract was prepared and
fractionated through Bio-Rex 70 and MonoQ essentially as described
(49). Eggs were obtained from mature female X. laevis and
extracted by the crushed cell method (49). The resulting extracts were
applied to Bio-Rex 70 (Na+ form, Bio-Rad) previously
equilibrated in Buffer A (100 mM) (20 mM HEPES,
pH 7.5, 5 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 10 mM
The ISWI-A peak was further purified by sedimentation on a 5-20%
sucrose gradient in Buffer A (49) for 28 h at 41,000 rpm in an SW
41 rotor.
The ISWI-B, ISWI-C, and ISWI-D complexes were each purified through
gradient elution on MonoS and heparin-Sepharose. Peak fractions from
the MonoQ column were dialyzed versus Buffer A (0 mM) to a conductance equivalent to 100 mM NaCl
and applied to a MonoS 5/5 column previously equilibrated in Buffer A
(100). The column was washed with 5 column volumes Buffer A (100) and eluted with a linear gradient from Buffer A (100) to A (500) in 20 column volumes. Fractions were analyzed for ISWI content by immunoblot.
Elution positions for the individual ISWI complexes were as follows:
ISWI-B, 360 mM NaCl; ISWI-C, 350 mM NaCl,
ISWI-D, 330 mM NaCl. Each ISWI MonoS pool was dialyzed
versus Buffer A (0 mM) containing 0.1% Triton
X-100 to a conductance equivalent to 100 mM NaCl. Protein
samples were cleared by centrifugation and applied to 1-ml
heparin-Sepharose columns (HiTrap columns, Amersham Pharmacia Biotech)
previously equilibrated in Buffer A (100) plus 0.1% Triton X-100.
Columns were washed with 5 volumes A (100) and eluted with linear
gradients from Buffer A (100) to Buffer A (1000) in 20 column volumes,
buffers contained 0.1% Triton X-100. Elution positions for the
respective ISWI complexes were as follows: ISWI-B, 540 mM
NaCl; ISWI-C, 570 mM NaCl; ISWI-D, 540 mM NaCl.
ATPase assays were performed as described (49, 50).
Octamer Mobilization and Spacing Assays--
Nucleosome
reconstitution and histone octamer mobilization experiments were
performed as described (50) using the quantities indicated in the
figure legends.
Chromatin assembly and spacing assays were performed as described (45).
In the indicated reactions, 1 µl of anti-ISWI antiserum or preimmune
serum from the same rabbit was included. Additional spacing assays with
salt-dialyzed chromatin were performed essentially as described
(25).
Cloning of Xenopus ISWI and Fractionation into Multiple
Complexes--
We began our studies of ISWI in Xenopus by
cloning an ISWI cDNA from an oocyte library. A single class of
cDNA coding for a protein of 1037 amino acids was isolated
(GenBankTM accession number AF292095). Comparison of the
predicted amino acid sequence of the Xenopus cDNA (see
Fig. 1) revealed closest similarity to
the human ISWI homolog hSNF2H (51). The Xenopus protein
contains the conserved sequence blocks diagnostic of the SNF2
superfamily (52) in addition to considerable sequence identity with
both human ISWI homologs in the carboxyl-terminal portion of the
protein including the SANT domain (53). We utilized this highly
conserved carboxyl-terminal region to elicit antibodies (amino acids
724-955). The antibody detects a protein of the predicted size in egg
and oocyte extracts (data not shown); we have subsequently utilized it
as a tool for the purification of ISWI from egg extracts.
The first two steps of ISWI purification are outlined in Fig.
2A. All the detectable ISWI
bound the initial cation exchange column and was eluted at moderate
salt. Surprisingly, gradient elution of the 0.5 M Bio-Rex
fraction on MonoQ reproducibly yielded four distinct peaks of ISWI by
immunoblot that we provisionally named ISWI-A, -B, -C, and -D (see Fig.
2B). The ISWI-C peak was the most abundant on the MonoQ
gradient. RbA p48/p46, a subunit of the Drosophila NURF
complex (54), did not copurify with ISWI at this step. In fact, the
prominent RbA p48/p46 peak on the MonoQ gradient is associated with the
Xenopus Mi-2 complex (49).
ATPase activity assays of the gradient fractions revealed a major peak
of DNA-stimulated ATPase activity coincident with the peak of RbA
p48/p46 in fractions 31-33. Although we do not currently know the
identity of this ATPase, it is not associated with either Mi-2 or ISWI
(data not shown (49)). Surprisingly, the ISWI-A peak coincided with
ATPase activity stimulated by free histones. ISWI-D, as expected,
copurified with nucleosome-stimulated ATPase activity. The ISWI-B and
-C complexes were associated with minor peaks of nucleosome-stimulated
ATPase, although their activities were partially obscured by the robust
DNA-stimulated ATPase in this region of the gradient.
Purification of a Histone-dependent ATPase
Complex--
ISWI-A was further purified by sedimentation on a sucrose
gradient. Histone-stimulated ATPase activity was found in fractions 22-24 (see Fig. 3A) whereas
immunoblots revealed ISWI in fractions 23-25 (Fig. 3B).
ATPase activity precisely cosedimented with three polypeptides of 200, 21, and 15 kDa at a position consistent with a molecular mass of 250 kDa (Fig. 3A and data not shown). Although ISWI protein
closely cosedimented with histone-dependent ATPase activity, it was not present at comparable stoichiometry to p200, p21,
and p15. We are currently investigating the identity of p200, p21, and
p15 in order to determine whether their copurification with ISWI is
functionally relevant.
To determine the relationship between these three polypeptides and
ATPase activity, we performed a cross-linking assay using a
radiolabeled ATP analog (8-azido-[ ISWI-C Represents a Functional Homolog of ACF--
ISWI-C was
purified through the chromatographic steps summarized in Fig.
4A. Nucleosome-stimulated
ATPase activity coeluted with ISWI in fractions 31-34 of the final
column (data not shown). Three polypeptides of 185, 175, and 135 kDa,
respectively, were present in the purified complex (see Fig.
4A), and higher percentage gels fail to reveal additional
subunits (data not shown). This polypeptide composition is essentially
identical to that reported for the Drosophila ACF complex
(35-36). We confirmed the identity of the 135-kDa subunit as ISWI
using immunoblots and by mass spectrometry (data not shown).
Peptide sequence from the 185-kDa protein yielded a single peptide
(KEREEAAARIRK) with an exact match to a human EST clone (GenBankTM accession number AA112166). This EST clone was
subsequently found to be contained in its entirety within a protein
recently described by different groups as either WCRF180 (29), BAZ1A (55), or hAcf1 (27). We conclude that ISWI-C, based on the similarity
in polypeptide profile as well as the chemical identification of p185
as a sequence relative of human and Drosophila Acf1,
represents a new member of the ACF-CHRAC complex family.
The primary difference between the Xenopus and
Drosophila ACF complexes and the recently described WCRF and
hACF complexes is the presence of a p175 species in the
Xenopus and Drosophila ACF complexes. The p175
component of Drosophila ACF has been identified as similar
or identical to the Acf1 protein based on peptide chemistry and on
immunoreactivity (26). We have compared peptide maps obtained by mass
spectrometry of Xenopus p185 and p175. We find, in contrast
to Drosophila ACF, that these two proteins are distinct (data not shown). We are currently pursuing the identity of the Xenopus p175 protein; there are no candidate sequences in
the current data bases.
To assess the ability of Xenopus ACF (hereafter referred to
as xACF) to perturb histone-DNA interactions, we utilized an octamer mobilization assay (reviewed in Ref. 56) previously used for Drosophila NURF and CHRAC (57-58). Nucleosomes were
assembled by salt dialysis on a 250-base pair fragment of the
Xenopus TR
As Drosophila ACF was initially characterized as an
energy-dependent chromatin assembly factor (25-26), we
have investigated the ability of Xenopus ACF to organize
nucleosomal arrays. We first utilized a chromatin assembly system from
Xenopus oocyte extracts consisting of a partially purified
H3·H4-N1·N2 complex, purified H2A/H2B heterodimers, and
spacing activity provided by either crude oocyte extracts or the
previously defined spacing fraction (45). As seen in Fig.
4D, this reconstituted system directs the assembly of a
nucleosomal array with physiologic spacing (see 1st and
2nd lanes). The addition of anti-ISWI antibody,
but not preimmune serum, results in a loss of chromatin organization. The spacing fraction can rescue the ISWI-depleted reaction (Fig. 4D), and immunoblot analysis reveals that ISWI is present in
the spacing fraction (data not shown). Like the original spacing
fraction, Xenopus ACF is capable of rescuing the spacing and
assembly properties of the ISWI-depleted reaction (see Fig.
4D). Drosophila ACF can reorganize nucleosomes
deposited by salt gradient dialysis (25). We tested xACF for similar
activity in a system consisting solely of purified core histones
deposited by salt dialysis and purified xACF1. Treatment of the
resulting minichromosomes with xACF1 resulted in a regularly spaced
nucleosomal array with up to five or six nucleosomes visible following
micrococcal nuclease digestion (Fig. 4E). In addition,
octamer spacing on the xACF-treated minichromosomes changes from a
close-packed to a uniformly spaced configuration in an
ATP-dependent manner (Fig. 4E).
ISWI-B and ISWI-D Represent Novel ISWI Complexes--
ISWI-B was
purified through the chromatographic steps outlined in Fig.
5A. ISWI copurified with a
single polypeptide of 200 kDa (Fig. 5A) and with
nucleosome-stimulated ATPase activity in the final purification step,
gradient elution on heparin-Sepharose (data not shown). Sedimentation
analysis indicated a molecular mass of approximately 500 kDa (data not
shown). Peptide mapping of p200 by tryptic digestion and mass
spectrometry failed to generate matches to any proteins in the current
data base (data not shown).
The final peak, ISWI-D, was purified through chromatography on MonoS
and heparin (see Fig. 6A). A
sharp peak of nucleosome-stimulated ATPase activity exactly coeluted
with ISWI on the final purification step (data not shown). Polypeptides
of 200, 135, and 70 kDa copurified in the ISWI-D complex (shown in Fig.
6A). However, electrophoresis of a greater quantity of
protein on higher percentage gels revealed the presence of additional
polypeptides of 55 and 17 kDa (see Fig. 6A). Peptide mapping
for the p200, p70, and p55 ISWI-D polypeptides failed to generate
matches in the current data bases. The p200 polypeptide found in the
ISWI-B complex is distinct from the ISWI-D p200 protein by mass
spectrometry (data not shown). Additionally, mass spectrometry rules
out copurification of ISWI with Xenopus topoisomerase II as
initially reported for Drosophila CHRAC (24). We were also
unable to detect copurification of ISWI with topoisomerase II in
any of these complexes by immunoblot analysis (data not shown) using
We have also examined the capacity of the ISWI-B and ISWI-D complexes
to mobilize histone octamers in our standard mobilization assay. Like
xACF, both ISWI-B and ISWI-D move histone octamers in an
ATP-dependent fashion (see Fig. 5B and Fig.
6B). Additionally, both complexes, like xACF, reposition
octamers toward the center of the DNA fragment (see Fig.
6B). Comparison of the mobilization activities of these
three complexes failed to reveal significant qualitative or
quantitative differences.
This report describes the first systematic characterization of all
major forms of ISWI from a vertebrate, X. laevis.
The ISWI protein presented considerable biochemical complexity,
fractionating into four forms with distinct biochemical properties and
subunit composition. In Saccharomyces cerevisiae, the two
ISWI genes form only two types of protein complex
(32). In Drosophila embryos, three complexes containing
ISWI have been described (reviewed in Refs. 12, 19, and 20), but
two, ACF and CHRAC, are clearly related (26, 28). Undoubtedly, the
developmental program of Xenopus, with an early period of
rapid nuclear divisions, places a special burden on the machinery for
chromatin assembly. The multiple ISWI complexes described here may
reflect those specialized demands.
Human cells, Xenopus eggs, and Drosophila embryos
all contain ISWI complexes featuring an Acf1 homolog (26-30). In
addition, S. cerevisiae contains a homolog (YGL133w)
suggesting that an ACF-like complex also exists in this organism. ACF
is thus likely to represent a fundamental activity in eukaryotic
nuclei. The differences in polypeptide composition found in the various
members of the ACF/CHRAC family likely represent variations on a common theme. As depicted in Fig. 7, ISWI and
Acf1 associate to form a common structural and functional module.
Functionality, such as differential partitioning within the genome, may
be added to this module by association with accessory proteins like the
histone fold proteins of CHRAC or p175 of xACF. Elucidation of the
precise variations in composition and function for this interesting
family of chromatin-dependent ATPases should provide
important clues into mechanisms for assembly of specialized chromatin
structures.
We have initiated an attempt to understand the functions of the
Xenopus ISWI complexes by defining their nucleosome
mobilization properties. Each complex, regardless of polypeptide
composition, mobilized histone octamers toward the center of the DNA
fragment like the Drosophila CHRAC complex (58) and unlike
the Drosophila NURF complex (57). This repositioning of
histones relative to DNA sequence required a hydrolyzable form of ATP,
operated at moderate monovalent and divalent cation concentrations, and
occurred in cis on a single DNA fragment. Mechanistically,
we favor the model recently proposed by Wu and colleagues (57), which
stipulates that nucleosome motion occurs in small, discrete steps.
Central to this proposal is the notion that ATP hydrolysis by the ISWI ATPase leads to lowered activation energy for short translational sliding by the histone octamer. The NURF complex, based on the bidirectional character of its mobilization activity, is predicted to
generate a relatively unrestricted random walk of histones to a
thermodynamically favorable position (57). In marked contrast, the
CHRAC complex (58) and all three Xenopus complexes exhibit strong directionality in their mobilization activity. We propose that
proteins other than ISWI in the Xenopus ISWI complexes and in CHRAC restrict the potential locations available for octamer motion.
This restriction serves functionally to maximize the amount of DNA
protruding from each end of the nucleosome. This hypothesis predicts
that proteins in the Xenopus ISWI complexes other than ISWI
interact with extranucleosomal DNA. Activity of this nature on a
mononucleosome is also predicted to translate into spacing in the
context of a nucleosomal array where adjacent nucleosomes rather than
DNA ends provide the limits for available positions. The definition, in
molecular terms, of the remaining ISWI-associated proteins described in
this work should prove valuable in the mechanistic determination of
histone octamer mobilization by this class of enzymes as well as their
roles in influencing chromatin structure and DNA function in
vivo.
Protein sequence determination was performed
by the Protein/DNA Technology Center of the Rockefeller University.
Mass spectrometry for the ISWI-B and ISWI-D polypeptides was performed
at the Protein/DNA Technology Center of the Rockefeller University.
Mass spectrometry of the xACF polypeptides was performed by Dr. Alfred
Yergey of the Section on Mass Spectrometry and Metabolism, Laboratory
of Cellular and Molecular Biophysics, NICHD. We thank Dr. Peter Becker for the kind gift of recombinant Drosophila ISWI expression
clones and Dr. Dan Bogenhagen for the gift of topoisomerase II
antisera. We thank the members of the Laboratory of Molecular
Embryology for their help and advice throughout the course of this work.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: Sangamo BioSciences, Inc., Point Richmond Tech
Center, 501 Canal Blvd., Suite A100, Richmond, CA 94804.
¶
Current address: Laboratory of Receptor Biology and Gene
Expression, NCI, National Institutes of Health, Bethesda, MD 20892.
**
To whom correspondence should be addressed: Emory University, Dept.
of Pathology, Woodruff Memorial Research Bldg., Rm. 7105-B, 1639 Pierce
Dr., Atlanta, GA 30322. Tel.: 404-712-9666; Fax: 404-727-8540; E-mail
pwade@emory.edu.
Published, JBC Papers in Press, August 14, 2000, DOI 10.1074/jbc.M006041200
The abbreviations used are:
RT-PCR, reverse
transcriptase-polymerase chain reaction;
AMP-PNP, adenosine
5'-(
Multiple ISWI ATPase Complexes from Xenopus
laevis
FUNCTIONAL CONSERVATION OF AN ACF/CHRAC HOMOLOG*
§,
¶,
¶,
,
§, and
**
Laboratory of Molecular Embryology, NICHD,
National Institutes of Health, Bethesda, Maryland 20892 and
John Curtin School of Medical Research, The Australian National
University, Canberra, ACT 2601, Australia
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-glycerophosphate, 0.5 mM dithiothreitol, 10% glycerol, 0.2 mM
phenylmethylsulfonyl fluoride, 1 µg/ml leupeptin, numbers in
parentheses indicate millimolar concentration of NaCl) at a ratio of 10 mg of protein per ml packed bed volume. The column was washed with 4 volumes of Buffer A (100) and eluted with 3 volumes of Buffer A (500).
Fractions containing approximately 80% of the eluted protein from the
Buffer A (500) elution were pooled and dialyzed versus
Buffer A (0) to a conductance equivalent to 100 mM NaCl.
The protein pool was cleared by centrifugation and applied to a MonoQ
10/10 column previously equilibrated in Buffer A (100). The column was
washed with 5 volumes of Buffer A (100) and eluted with a linear
gradient from Buffer A (100) to A (500) in 20 column volumes. Fractions
were analyzed for ISWI content by immunoblot.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (84K):
[in a new window]
Fig. 1.
Xenopus ISWI is homologous to
hSNF2H. The deduced amino acid sequence of Xenopus ISWI
(xISWI) was aligned manually with the amino acid sequences
of hSNF2H, hSNF2L, and Drosophila ISWI (dm ISWI).
The boxed regions numbered I-VI represent sequence blocks
characteristic of the SNF2 superfamily (52). The conserved SANT domain
(53) is boxed and labeled.

View larger version (14K):
[in a new window]
Fig. 2.
Xenopus egg extracts contain
multiple forms of ISWI. A, the fractionation scheme
from egg extract is summarized in the diagram. The
inset immunoblot depicts the elution of ISWI on the
Bio-Rex 70 column. B, the panels depict immunoblots of
selected fractions from the gradient elution on MonoQ. The individual
ISWI peaks are indicated in the figure. C, ATPase assays
were performed as described under "Experimental Procedures" using
free DNA, purified core histones, or chicken erythrocyte
mononucleosomes as substrates. The graph depicts picomoles of ATP
hydrolyzed as a function of fraction number.

View larger version (20K):
[in a new window]
Fig. 3.
A novel histone-dependent ATPase
activity copurifies with a three-polypeptide complex.
A, histone-stimulated ATPase activity of sucrose gradient
fractions is depicted in the graph. ATPase assays were performed as
described under "Experimental Procedures." B, an
immunoblot of selected sucrose gradient fractions was probed with
anti-ISWI antibody. C, aliquots of the indicated sucrose
gradient fractions were resolved on SDS-PAGE (4-20% acrylamide
gradient) and stained with Coomassie Blue. Arrows indicate
the 200-, 21-, and 15-kDa proteins cosedimenting with ATPase activity.
D, an ATP cross-linking assay was performed with
8-azido-ATP. Two microliters of sucrose fraction 23 were incubated with
or without core histones and 8-azido-ATP for 30 min at room
temperature. Cross-linking was initiated with a Stratalinker, and
samples were resolved in 4-20% gradient SDS gels that were
subsequently dried and exposed to x-ray film.
-32P]ATP).
The 200-kDa polypeptide cross-linked to ATP in the presence of UV light
in a reaction stimulated by core histones (see Fig. 3D). As
histones represent the vast majority of protein in the reaction
(roughly 5-6 orders of magnitude more abundant than ISWI-A), it is not
surprising that they are nonspecifically cross-linked. We conclude that
p200 represents a candidate ATPase stimulated by free histones. To our
knowledge, this is the first description of an ATPase stimulated solely
by free histones and not by DNA or nucleosomes. The biological
relevance of this activity is currently unknown.

View larger version (42K):
[in a new window]
Fig. 4.
Xenopus ISWI-C a functional
homolog of Drosophila ACF. A, the flow
chart depicts the purification steps for the ISWI-C complex which we
have renamed xACF. Aliquots of fractions from the heparin column were
resolved on 6% SDS-PAGE and stained with silver. The bands
corresponding to p185 (xACF1), p175, and ISWI are indicated in the
figure. B, the mixture of positional isomers obtained
following nucleosome assembly on the 250-base pair fragment of the
Xenopus TR
A promoter. The positions of histone octamers
depicted in the cartoons were determined by micrococcal nuclease
mapping (50). C, autoradiogram of a native polyacrylamide
gel following nucleosome mobilization. The nucleosome at position 2 was
isolated and used in an octamer mobilization assay. Positions of free
DNA and unique nucleosome positions are indicated on the figure.
Reactions were performed in the presence or absence of 1 mM
MgATP, AMP-PNP, or GTP as indicated. 1 microliter (100 ng) of purified
xACF (MonoS fraction) or 1 µl (120 ng) of recombinant
Drosophila ISWI was added as indicated. In the indicated
lanes, the K159R mutant Drosophila protein (61) was used.
D, chromatin was assembled and analyzed by micrococcal
nuclease digestion and agarose gel. Two time points of digestion are
shown for each assembly reaction. ISWI antibody, preimmune serum,
spacing fraction, and Xenopus ACF were added as depicted in
the figure. E, histones were deposited on DNA by standard
salt dialysis. The resulting minichromosomes were incubated with xACF
in the presence or absence of 1 mM ATP as depicted in the
figure. Arrowheads on the right indicate the
migration of DNA fragments resulting from the production of mono, di,
tri, tetra, and penta-nucleosomal particles.
A promoter (59). The resulting uniquely
positioned nucleosomes have been characterized by micrococcal nuclease
mapping (50), and the positions are summarized in cartoon form in Fig.
4B. Following isolation of the unique position termed N2 by
native polyacrylamide gel electrophoresis, we incubated this nucleosome
with purified xACF complex. Recombinant Drosophila ISWI
served as a positive control (57-58). As previously reported (57-58),
recombinant ISWI shifted the position of the histone octamer to a new
position, namely to the end of the DNA fragment (see Fig.
4C). In contrast, purified xACF shifted the octamer position
toward the center (see Fig. 4C). This octamer
mobilization required ATP hydrolysis because a non-hydrolyzable ATP
analog did not promote this reaction nor did GTP. Additionally, as the
reaction did not result in the accumulation of free DNA (see Fig.
4C), octamer movement must occur in cis. The
Drosophila CHRAC complex mobilizes nucleosomes in a similar manner, albeit on an unrelated DNA fragment (58). The
Drosophila NURF complex, on the other hand, moves octamers
bidirectionally on DNA and prefers, on a fragment of the
Drosophila hsp70 promoter, to reposition histones near the
end of the fragment (57). Recombinant Drosophila ISWI
preferentially repositions the octamer at the fragment end
(57-58).

View larger version (20K):
[in a new window]
Fig. 5.
The ISWI-B complex consists of ISWI and a
200-kDa protein. A, the purification scheme for ISWI-B
is outlined in the diagram. Aliquots from the heparin column were
resolved on 10% SDS-PAGE and stained with Coomassie Blue. The bands
corresponding to ISWI and p200 are indicated. B, nucleosome
mobilization assays were performed as described under "Experimental
Procedures." ATP, AMP-PNP, and GTP were added as indicated. ISWI-B
complex (MonoS fraction) was added where indicated (1 µl, 80 ng). The
positions of individual nucleosomes are indicated on the figure.
-Xenopus topoisomerase II (60).

View larger version (36K):
[in a new window]
Fig. 6.
ISWI-D is a five-polypeptide complex.
A, the purification scheme for ISWI-D is summarized in the
diagram. Aliquots of fractions from the final purification step were
resolved on 10% SDS-PAGE and stained with Coomassie Blue. The bands
corresponding to p200, ISWI, and p70 are indicated in the figure. A
higher percentage gel of the ISWI-D peak was loaded with severalfold
more protein and stained with Coomassie to demonstrate the presence of
p55 and p17. B, nucleosome mobilization was performed as
described for ISWI-B and xACF. ATP, AMP-PNP, and GTP were added as
indicated. ISWI-D (MonoS fraction) was added where indicated (1 µl,
40 ng). The positions of free DNA and individual nucleosomes are
indicated on the figure.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (12K):
[in a new window]
Fig. 7.
The ACF/CHRAC family of chromatin remodeling
complexes. The model describes the potential relationships of the
known members of the ACF/CHRAC family of chromatin-remodeling enzymes.
Additional features of the model are described in the text.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
,
-imino)triphosphate;
PAGE, polyacrylamide gel
electrophoresis.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Wu, C.
(1997)
J. Biol. Chem.
272,
28171-28174
2.
Strahl, B. D.,
and Allis, C. D.
(2000)
Nature
403,
41-45
3.
DePamphilis, M. L.
(1999)
BioEssays
21,
5-16
4.
Henikoff, S.
(1997)
Curr. Opin. Cell. Biol.
9,
388-395
5.
Schlissel, M. S.
(2000)
Science
287,
438-440
6.
Smerdon, M. J.,
and Conconi, A.
(1999)
Prog. Nucleic Acids Res. Mol. Biol.
62,
227-255
7.
Moggs, J. G.,
and Almouzni, G.
(1999)
Biochimie (Paris)
81,
45-52
8.
Peterson, C. L.
(1998)
Cold Spring Harbor Symp. Quant. Biol.
63,
545-552
9.
Sogo, J. M.,
Stahl, H.,
Koller, T.,
and Knippers, R.
(1986)
J. Mol. Biol.
189,
189-204
10.
Studitsky, V. M.,
Kassavetis, G. A.,
Geiduschek, E. P.,
and Felsenfeld, G.
(1997)
Science
278,
1960-1963
11.
Kornberg, R. D.,
and Lorch, Y.
(1999)
Curr. Opin. Genet. & Dev.
9,
148-151
12.
Vignali, M.,
Hassan, A. H.,
Neely, K. E.,
and Workman, J. L.
(2000)
Mol. Cell. Biol.
20,
1899-1910
13.
Kingston, R. E.,
and Narlikar, G. J.
(1999)
Genes Dev.
13,
2339-2352
14.
Armstrong, J. A.,
and Emerson, B. M.
(1998)
Curr. Opin. Genet. & Dev.
8,
165-172
15.
Cairns, B. R.
(1998)
Trends Biochem. Sci.
23,
20-25
16.
Burns, L. G.,
and Peterson, C. L.
(1997)
Biochim. Biophys. Acta
1350,
159-168
17.
Muchardt, C.,
and Yaniv, M.
(1999)
J. Mol. Biol.
293,
187-198
18.
Tsukiyama, T.,
and Wu, C.
(1997)
Curr. Opin. Genet. & Dev.
7,
182-191
19.
Varga-Weisz, P. D.,
and Becker, P. B.
(1998)
Curr. Opin. Cell Biol.
10,
346-353
20.
Imbalzano, A. N.
(1998)
Crit. Rev. Eukaryotic Gene Expr.
8,
225-255
21.
Tsukiyama, T.,
and Wu, C.
(1995)
Cell
83,
1011-1020
22.
Tsukiyama, T.,
Daniel, C.,
Tamkun, J.,
and Wu, C.
(1995)
Cell
83,
1021-1026
23.
Varga-Weisz, P. D.,
Blank, T. A.,
and Becker, P. B.
(1995)
EMBO J.
14,
2209-2216
24.
Varga-Weisz, P. D.,
Wilm, M.,
Bonte, E.,
Dumas, K.,
Mann, M.,
and Becker, P. B.
(1997)
Nature
388,
598-602
25.
Ito, T.,
Bulger, M.,
Pazin, M. J.,
Kobayashi, R.,
and Kadonaga, J. T.
(1997)
Cell
90,
145-155
26.
Ito, T.,
Levenstein, M. E.,
Fyodorov, D. V.,
Kutach, A. K.,
Kobayashi, R.,
and Kadonaga, J. T.
(1999)
Genes Dev.
13,
1529-1539
27.
Poot, R. A.,
Dellaire, G.,
Hulsmann, B. B.,
Grimaldi, M. A.,
Corona, D. F.,
Becker, P. B.,
Bickmore, W. A.,
and Varga-Weisz, P. D.
(2000)
EMBO J.
19,
3377-3387
28.
Corona, D. F.,
Eberharter, A.,
Budde, A.,
Deuring, R.,
Ferrari, S.,
Varga-Weisz, P.,
Wilm, M.,
Tamkun, J.,
and Becker, P. B.
(2000)
EMBO J.
19,
3049-3059
29.
Bochar, D. A.,
Savard, J.,
Wang, W.,
Lafleur, D. W.,
Moore, P.,
Cote, J.,
and Shiekhattar, R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1038-1043
30.
LeRoy, G.,
Loyola, A.,
Lane, W. S.,
and Reinberg, D.
(2000)
J. Biol. Chem.
275,
14787-14790
31.
LeRoy, G.,
Orphanides, G.,
Lane, W. S.,
and Reinberg, D.
(1998)
Science
282,
1900-1904
32.
Tsukiyama, T.,
Palmer, J.,
Landel, C. C.,
Shiloach, J.,
and Wu, C.
(1999)
Genes Dev.
13,
686-697
33.
Trachtulcova, P.,
Janatova, I.,
Kohlwein, S. D.,
and Hasek, J.
(2000)
Yeast
16,
35-47
34.
Deuring, R.,
Fanti, L.,
Armstrong, J. A.,
Sarte, M.,
Papoulas, O.,
Prestel, M.,
Daubresse, G.,
Verardo, M.,
Moseley, S. L.,
Berloco, M.,
Tsukiyama, T.,
Wu, C.,
Pimpinelli, S.,
and Tamkun, J. W.
(2000)
Mol. Cell
5,
355-365
35.
Newport, J.,
and Kirschner, M.
(1982)
Cell
30,
675-686
36.
Newport, J.,
and Kirschner, M.
(1982)
Cell
30,
687-696
37.
Almouzni, G.,
and Wolffe, A. P.
(1993)
Exp. Cell Res.
205,
1-15
38.
Laskey, R. A.,
Mills, A. D.,
and Morris, N. R.
(1977)
Cell
10,
237-243
39.
Almouzni, G.,
and Mechali, M.
(1988)
EMBO J.
7,
665-672
40.
Almouzni, G.,
and Mechali, M.
(1988)
EMBO J.
7,
4355-4365
41.
Glikin, G. C.,
Ruberti, I.,
and Worcel, A.
(1984)
Cell
37,
33-41
42.
Shimamura, A.,
Tremethick, D.,
and Worcel, A.
(1988)
Mol. Cell. Biol.
8,
4257-4269
43.
Tremethick, D.,
Zucker, K.,
and Worcel, A.
(1990)
J. Biol. Chem.
265,
5014-5023
44.
Gaillard, P. H.,
Martini, E. M.,
Kaufman, P. D.,
Stillman, B.,
Moustacchi, E.,
and Almouzni, G.
(1996)
Cell
86,
887-896
45.
Tremethick, D. J.,
and Frommer, M.
(1992)
J. Biol. Chem.
267,
15041-15048
46.
Gelius, B.,
Wade, P.,
Wolffe, A.,
Wrange, O.,
and Ostlund Farrants, A. K.
(1999)
Eur. J. Biochem.
262,
426-434
47.
Ausubel, F., Brent, R., Kingston, R. E., Moore, D. D.,
Seidman, J. G., Smith, J. A., and Struhl, K. (eds) (1995)
Short Protocols in Molecular Biology, 3rd Ed., pp.
6-3-6-12 and 15-13-15-15, John Wiley & Sons, Inc., New York
48.
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, pp. 53-139, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
49.
Wade, P. A.,
Jones, P. L.,
Vermaak, D.,
and Wolffe, A. P.
(1998)
Curr. Biol.
8,
843-846
50.
Guschin, D.,
Wade, P. A.,
Kikyo, N.,
and Wolffe, A. P.
(2000)
Biochemistry
39,
5238-5245
51.
Aihara, T.,
Miyoshi, Y.,
Koyama, K.,
Suzuki, M.,
Takahashi, E.,
Monden, M.,
and Nakamura, Y.
(1998)
Cytogenet. Cell Genet.
81,
191-193
52.
Eisen, J. A.,
Sweder, K. S.,
and Hanawalt, P. C.
(1995)
Nucleic Acids Res.
23,
2715-2723
53.
Aasland, R.,
Stewart, A. F.,
and Gibson, T.
(1996)
Trends Biochem. Sci.
21,
87-88
54.
Martinez-Balbas, M. A.,
Tsukiyama, T.,
Gdula, D.,
and Wu, C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
132-137
55.
Jones, M. H.,
Hamana, N.,
Nezu, J.-I.,
and Shimane, M.
(2000)
Genomics
63,
40-45
56.
Guschin, D.,
and Wolffe, A. P.
(1999)
Curr. Biol.
9,
742-746
57.
Hamiche, A.,
Sandaltzopoulos, R.,
Gdula, D. A.,
and Wu, C.
(1999)
Cell
97,
833-842
58.
Langst, G.,
Bonte, E. J.,
Corona, D. F.,
and Becker, P. B.
(1999)
Cell
97,
843-852
59.
Ranjan, M.,
Wong, J.,
and Shi, Y. B.
(1994)
J. Biol. Chem.
269,
24699-24705
60.
Luke, M.,
and Bogenhagen, D. F.
(1989)
Dev. Biol.
136,
459-468
61.
Corona, D. F.,
Langst, G.,
Clapier, C. R.,
Bonte, E. J.,
Ferrari, S.,
Tamkun, J. W.,
and Becker, P. B.
(1999)
Mol. Cell
2,
239-245
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. Dang, M. N. Kagalwala, and B. Bartholomew The Dpb4 Subunit of ISW2 Is Anchored to Extranucleosomal DNA J. Biol. Chem., July 6, 2007; 282(27): 19418 - 19425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Stewart, J. Sommerville, and J. Wong Dynamic Regulation of Histone Modifications in Xenopus Oocytes through Histone Exchange. Mol. Cell. Biol., September 1, 2006; 26(18): 6890 - 6901. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schwanbeck, H. Xiao, and C. Wu Spatial Contacts and Nucleosome Step Movements Induced by the NURF Chromatin Remodeling Complex J. Biol. Chem., September 17, 2004; 279(38): 39933 - 39941. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. McConnell, M. E. Gelbart, and T. Tsukiyama Histone Fold Protein Dls1p Is Required for Isw2-Dependent Chromatin Remodeling In Vivo Mol. Cell. Biol., April 1, 2004; 24(7): 2605 - 2613. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Davis and C. J. Bardeen The Connection between Chromatin Motion on the 100 nm Length Scale and Core Histone Dynamics in Live XTC-2 Cells and Isolated Nuclei Biophys. J., January 1, 2004; 86(1): 555 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Flaus and T. Owen-Hughes Dynamic Properties of Nucleosomes during Thermal and ATP-Driven Mobilization Mol. Cell. Biol., November 1, 2003; 23(21): 7767 - 7779. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loyola, J.-Y. Huang, G. LeRoy, S. Hu, Y.-H. Wang, R. J. Donnelly, W. S. Lane, S.-C. Lee, and D. Reinberg Functional Analysis of the Subunits of the Chromatin Assembly Factor RSF Mol. Cell. Biol., October 1, 2003; 23(19): 6759 - 6768. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Whitehouse, C. Stockdale, A. Flaus, M. D. Szczelkun, and T. Owen-Hughes Evidence for DNA Translocation by the ISWI Chromatin-Remodeling Enzyme Mol. Cell. Biol., March 15, 2003; 23(6): 1935 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Vary Jr., V. K. Gangaraju, J. Qin, C. C. Landel, C. Kooperberg, B. Bartholomew, and T. Tsukiyama Yeast Isw1p Forms Two Separable Complexes In Vivo Mol. Cell. Biol., January 1, 2003; 23(1): 80 - 91. [Abstract] [Full Text] |
||||
![]() |
D. V. Fyodorov and J. T. Kadonaga Binding of Acf1 to DNA Involves a WAC Motif and Is Important for ACF-Mediated Chromatin Assembly Mol. Cell. Biol., September 15, 2002; 22(18): 6344 - 6353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lim, M. Bustin, V. V. Ogryzko, and Y. V. Postnikov Metastable Macromolecular Complexes Containing High Mobility Group Nucleosome-binding Chromosomal Proteins in HeLa Nuclei J. Biol. Chem., May 31, 2002; 277(23): 20774 - 20782. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Langst and P. B. Becker Nucleosome mobilization and positioning by ISWI-containing chromatin-remodeling factors J. Cell Sci., March 9, 2002; 114(14): 2561 - 2568. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamiche, J.-G. Kang, C. Dennis, H. Xiao, and C. Wu Histone tails modulate nucleosome mobility and regulate ATP-dependent nucleosome sliding by NURF PNAS, November 20, 2001; (2001) 251421398. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Loyola, G. LeRoy, Y.-H. Wang, and D. Reinberg Reconstitution of recombinant chromatin establishes a requirement for histone-tail modifications during chromatin assembly and transcription Genes & Dev., November 1, 2001; 15(21): 2837 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Fazzio, C. Kooperberg, J. P. Goldmark, C. Neal, R. Basom, J. Delrow, and T. Tsukiyama Widespread Collaboration of Isw2 and Sin3-Rpd3 Chromatin Remodeling Complexes in Transcriptional Repression Mol. Cell. Biol., October 1, 2001; 21(19): 6450 - 6460. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hamiche, J.-G. Kang, C. Dennis, H. Xiao, and C. Wu Histone tails modulate nucleosome mobility and regulate ATP-dependent nucleosome sliding by NURF PNAS, December 4, 2001; 98(25): 14316 - 14321. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. MacCallum, A. Losada, R. Kobayashi, and T. Hirano ISWI Remodeling Complexes in Xenopus Egg Extracts: Identification as Major Chromosomal Components that Are Regulated by INCENP-aurora B Mol. Biol. Cell, January 1, 2002; 13(1): 25 - 39. [Abstract] [Full Text] [PDF] |
||||
| ||||